The relation between depression and parkin genotype: The CORE-PD study

Parkinsonism and Related Disorders

Volumn 17, Issue 10, 2011, Pages 740-744

  Srivastava, A ^a   Tang, M X ^a,b   Mejia Santana, H ^a   Rosado, L ^a   Louis, E D ^a,b,c   Caccappolo, E ^a   Comella, C ^d   Colcher, A ^e   Siderowf, A ^e   Jennings, D ^f   Nance, M ^g   Bressman, S ^h,i   Scott, W K ^j   Tanner, C ^k   Mickel, S ^l   Andrews, H ^m   Waters, C ^a   Fahn, S ^a   Cote, L ^a   Frucht, S ^a   Ford, B ^a   Alcalay, R N ^a   Ross, B ^a,c   Orbe Reilly, M ^a   Rezak, M ^n,o   Novak, K ^n,o   Friedman, J H ^p,q   Pfeiffer, R D ^r   Marsh, L ^s   Hiner, B ^t   Merle, D ^m   Ottman, R ^a,b,c,m   Clark, L N ^a   Marder, K ^a,b   more..

^a Columbia University ^*  (United States)

^b Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

^c Pennsylvania Hospital ^*  (United States)

^d The Institute for Neurodegenerative Disorders ^*  (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f INSTITUTE FOR NEURODEGENERATIVE DISORDERS   (United States)

^g PARK NICOLLET CLINIC   (United States)

^h BETH ISRAEL MEDICAL CENTER   (United States)

ⁱ ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^k PARKINSON S INSTITUTE   (United States)

^l MARSHFIELD CLINIC   (United States)

^m NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

ⁿ NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^o NORTHWESTERN UNIVERSITY   (United States)

^p Parkinson's Disease and Movement Disorders Center of NeuroHealth   (United States)

^q BROWN UNIVERSITY   (United States)

^r UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^s JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^t MEDICAL COLLEGE OF WISCONSIN   (United States)

more..

Author keywords

Depression; Early onset Parkinson's disease; Genetics; Neuropsychiatry; Parkin; Parkinson's disease

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; MONOAMINE OXIDASE INHIBITOR; PARKIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; EARLY ONSET PARKINSON DISEASE; FEMALE; GENE; GENE FUNCTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARK2 GENE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; QUESTIONNAIRE;

ADULT; AGE OF ONSET; DEPRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATION; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PHENOTYPE; RISK FACTORS; UBIQUITIN-PROTEIN LIGASES;

EID: 81255157833     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.07.008     Document Type: Article

References (30)

1. Cummings J.L. Depression and Parkinson's disease: a review. Am J Psychiatry 1992, 149:443-454.
2. Schrag A., Hovris A., Morley D., Quinn N., Jahanshahi M. Young-versus older-onset Parkinson's disease: impact of disease and psychosocial consequences. Mov Disord 2003, 18(11):1250-1256.
3. Ishihara L., Brayne C. A systematic review of depression and mental illness preceding Parkinson's disease. Acta Neurol Scand 2006, 113(4):211-220.
4. Kitada T., Asakawa S., Hattori N., Matsumine H., Yamamura Y., Minoshima S., et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392(6676):605-608.
5. Arabia G., Grossardt B.R., Geda Y.E., Carlin J.M., Bower J.H., Ahlskog J.E., et al. Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease. Arch Gen Psychiatry 2007, 64(12):1385-1392.
6. Clark L.N., Afridi S., Karlins E., Wang Y., Mejia-Santana H., Harris J., et al. Case-control study of the parkin gene in early-onset Parkinson disease. Arch Neurol 2006, 63(4):548-552.
7. Lohmann E., Thobois S., Lesage S., Broussolle E., du Montcel S.T., Ribeiro M.J., et al. A multidisciplinary study of patients with early-onset PD with and without parkin mutations. Neurology 2009, 72(2):110-116.
8. Pankratz N., Marder K.S., Halter C.A., Rudolph A., Shults C.W., Nichols W.C., et al. Clinical correlates of depressive symptoms in familial Parkinson's disease. Mov Disord 2008, 23(15):2216-2223.
9. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001, 16(9):606-613.
10. Beck A.T., Ward C.H., Mendelson M., Mock M., Erbaugh J. An inventory for measuring depression. Archi Gen Psychiatry 1961, 4:53-63.
11. Marder K., Tang M.X., Mejia-Santana H. Predictors of parkin mutations in early-onset Parkinson disease. Arch Neurol 2010, 67(6):731-738.
12. Marder K., Levy G., Louis E.D., Mejia-Santana H., Cote L., Andrews H., et al. Familial aggregation of early- and late-onset Parkinson's disease. Ann Neurol 2003, 54:507-513.
13. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J.Neurol Neurosurg Psychiatry 1992, 55(3):181-184.
14. Fahn S., Elton R. Recent developments in Parkinson's disease. Macmillan healthcare information 1987, 153-163. Committee. MotUD, 293-304. S. Fahn, C. Marsden, D. Calne, M. Goldstein (Eds.).
15. Spitzer R.L., Kroenke K., Williams J.B.W. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA 1999, 282(18):1737-1744. Patient Health Questionnaire Primary Care Study Group.
16. Devanand D.P., Sano M., Tang M.X., Taylor S., Gurland B.J., Wilder D., et al. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry 1996, 53(2):175-182.
17. Ravina B., Marder K., Fernandez H.H., Friedman J.H., McDonald W., Murphy D., et al. Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov Disord 2007, 22(8):1061-1068.
18. Leentjens A.F., Lousberg R., Verhey F.R. Markers for depression in Parkinson's disease. Acta Psychiatr Scand 2002, 106(3):196-201.
19. Visser M., Leentjens A.F.G., Marinus J., Stiggelbout A.M., van Hilten J.J. Reliability and validity of the Beck depression inventory in patient's with Parkinson's disease. Mov Disord 2006, 21:668-672.
20. Jankovic J., McDermott M., Carter J., Gauthier S., Goetz C., Golbe L., et al. Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson study group. Neurology 1990, 40(10):1529-1534.
21. Kirkwood S.C., Siemers E., Hodes M.E., Conneally P.M., Christian J.C., Foroud T. Subtle changes among presymptomatic carriers of the Huntington's disease gene. J Neurol Neurosurg Psychiatry 2000 Dec, 69(6):773-779.
22. Tandberg E., Larsen J.P., Aarsland D., Cummings J.L. The occurrence of depression in Parkinson's disease. A community-based study. Arch Neurol 1996, 53(2):175-179.
23. Looi J.C., Matis M., Ruzich M.J. Conceptualization of depression in Parkinson's disease. Neuropsychiatr Dis Treat 2005, 1(2):135-143.
24. McDonald M.W. Depression. Parkinson's disease: diagnosis and clinical management 2008, 159-177. Demos Medical Publishing, New York. 2nd ed. S.A. Factor, W.J. Weiner (Eds.).
25. Wang Y., Clark L.N., Louis E.D., Mejia-Santana H., Harris J., Cote L.J., et al. Risk of Parkinson disease in carriers of parkin mutations: estimation using the kin-cohort method. Arch Neurol 2008, 65(4):467-474.
26. Leentjens A.F., Van den Akker M., Metsemakers J.F., Lousberg R., Verhey F.R. Higher incidence of depression preceding the onset of Parkinson's disease: a register study. Mov Disord 2003, 18(4):414-418.
27. 18F]dopa PET and clinical study. Brain 2002, 125(Pt 10):2248-2256.
28. Von Coelln R., Thomas B., Savitt J.M., Lim K.L., Sasaki M., Hess E.J., et al. Loss of locus coeruleus neurons and reduced startle in parkin null mice. Proc Natl Acad Sci U.S.A 2004, 101(29):10744-10749.
29. Anand A., Charney D.S. Norepinephrine dysfunction in depression. J Clin Psychiatry 2000, 61(Suppl. 10):16-24.
30. Lohmann E., Periquet M., Bonifati V., Wood N.W., De Michele G., Bonnet A.M., et al. How much phenotypic variation can be attributed to parkin genotype?. Ann Neurol 2003, 54(2):176-185.